The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Open accessAbstract
OBJECTIVE: The Diabetes Control and Complications Trial (DCCT) demonstrated the powerful impact of glycemic control on the early manifestations of microvascular complications. Contemporary prospective data on the evolution of macrovascular and late microvascular complications of type 1 diabetes are limited. The Epidemiology of Diabetes Interventions and Complications (EDIC) study is a multicenter, longitudinal, observational study designed to use the well-characterized DCCT cohort of > 1,400 patients to determine the long-term effects of prior separation of glycemic levels on micro- and macrovascular outcomes. RESEARCH DESIGN AND METHODS: Using a standardized annual history and physical examination, 28 EDIC clinical centers that were DCCT clinics will follow the EDIC cohort for 10 years. Annual evaluation also includes resting electrocardiogram. Doppler ultrasound measurements of ankle/arm blood pressure, and screening for nephropathy. At regular intervals, a timed 4-h urine is collected, lipid profiles are obtained, and stereoscopic fundus photographs are taken. In addition, dual B-mode Doppler ultrasound scans of the common and internal carotid arteries will be performed at years 1 and 6 and at study end. RESULTS: Written informed consent was obtained from 96% of the DCCT subjects. The participants, compared with nonparticipants, tended to have better glycemic control at the completion of the DCCT and were more likely to have their diabetes care provided by DCCT personnel. The EDIC baseline measurement stratified by sex delineates multiple cardiovascular disease risk factor differences such as age (older in men), waist-to-hip ratio (higher in men). HDL cholesterol (lower in men), hypertension (more prevalent in men), and maximum intimal-medial thickness of common and internal carotid arteries (thicker in men). Of the original conventional treatment group, 69% have changed to continuous subcutaneous insulin infusion or multiple daily injections. Although the mean HbA1c difference between the intensive and conventional treatment groups narrowed at EDIC years 1 and 2, HbA1c remained significantly lower in the intensive group. Of all expected clinic visits, 95% were completed, and the quality of EDIC data is very similar to that observed in the DCCT. CONCLUSIONS: Although obvious problems exist in extended follow-up studies of completed clinical trials, these are balanced by the value of continued systematic observation of the DCCT cohort. In contrast to other epidemiologic studies, EDIC will provide 1) definitive data on type 1 as distinct from type 2 diabetes; 2) reliance on prospective rather than on cross-sectional analysis; 3) long-term follow-up in a large population; 4) consistent use of objective, reliable measures of outcomes and glycemia; and 5) observation of patients from before the onset of complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Dialysis Dose and Intradialytic Hypotension: Results from the HEMO Study
Mc Causland, F. R., Brunelli, S. M., & Waikar, S. S. (2013) · American Journal of Nephrology · doi:10.1159/000355958 · Cited by 2,690
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data
Turnbull, B. W. (1976) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1976.tb01597.x · Cited by 1,828
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., & Deckert, T. (1983) · Diabetologia · doi:10.1007/bf00284458 · Cited by 1,067
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34102-1 · Cited by 981
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694
A Proportional Hazards Model for Interval-Censored Failure Time Data
Finkelstein, D. M. (1986) · Biometrics · doi:10.2307/2530698 · Cited by 686
Krolewski, A. S., Kosinski, E. J., Warram, J. H., Stevens Leland, O., Busick, E. J., Cader Asmal, A., Rand, L. I., Christlieb, A. R., Bradley, R. F., & Kahn, C. R. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91086-1 · Cited by 654
The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy
The Diabetes Control and Complications Trial Research Group. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00001 · Cited by 602
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Drash, A. L., Ellis, D., LaPorte, R. E., & Kuller, L. H. (1990) · Diabetes · doi:10.2337/diab.39.9.1116 · Cited by 540
(1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80683-3 · Cited by 536
Anthropometric reference data and prevalence of overweight, United States, 1976-80.
Najjar, M. F., & Rowland, M. (1987) · PubMed · Cited by 521
Deckert, T., Poulsen, J. E., & Larsen, M. (1978) · Diabetologia · doi:10.1007/bf01228130 · Cited by 471
Klein, R. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010243030 · Cited by 470
Jensen, T., Borch-Johnsen, K., Kofoed-Enevoldsen, A., & Deckert, T. (1987) · Diabetologia · doi:10.1007/bf00274218 · Cited by 365
Clinical Measurement of Systolic Pressures in Limbs With Arterial Occlusive Disease
Carter, S. A. (1969) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1969.03150230083009 · Cited by 257
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.11.1829 · Cited by 249
Prevalence of asymptomatic myocardial ischaemia in diabetic subjects.
Koistinen, M. J. (1990) · BMJ · doi:10.1136/bmj.301.6743.92 · Cited by 221
Riley, W. A., Barnes, R. W., Bond, M. G., Evans, G., Chambless, L. E., & Heiss, G. (1991) · Journal of Neuroimaging · doi:10.1111/jon199114168 · Cited by 203
Diagnostic methods for peripheral arterial disease in the san luis valley diabetes study
Hiatt, W. R., Marshall, J. A., Baxter, J., Sandoval, R., Hildebrandt, W., Kahn, L. R., & Hamman, R. F. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90164-k · Cited by 196
Królewski, A. S., Warram, J. H., Rand, L. I., Christlieb, A. R., Busick, E. J., & Kahn, C. R. (1986) · Diabetes Care · doi:10.2337/diacare.9.5.443 · Cited by 190
Risk Factors for Progression of Background Retinopathy in Long-Standing IDDM
Janka, H. U., Warram, J. H., Rand, L. I., & Królewski, A. S. (1989) · Diabetes · doi:10.2337/diab.38.4.460 · Cited by 144
Multiple Factors in the Prediction of Risk of Proliferative Diabetic Retinopathy
Rand, L. I., Królewski, A. S., Aiello, L. M., Warram, J. H., Baker, R. S., & Maki, T. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132302 · Cited by 139
Winocour, P. H., Durrington, P. N., Ishola, M., Anderson, D. C., & Cohen, H. (1987) · BMJ · doi:10.1136/bmj.294.6588.1648 · Cited by 135
Early Atherosclerosis Is Retarded by Improved Long-Term Blood Glucose Control in Patients With IDDM
Jensen‐Urstad, K., Reichard, P., Rosfors, J. S., Lindblad, L. E., & Jensen‐Urstad, M. (1996) · Diabetes · doi:10.2337/diab.45.9.1253 · Cited by 128
Longevity of Diabetic Patients in Recent Years
Entmacher, P. S., Root, H. F., & Marks, H. H. (1964) · Diabetes · doi:10.2337/diab.13.4.373 · Cited by 121
Genetic Susceptibility to the Development of Retinopathy in Insulin-dependent Diabetics
Dornan, T., Ting, A., McPherson, C., Peckar, C., Mann, J. I., Turner, R. C., & Morris, P. J. (1982) · Diabetes · doi:10.2337/diab.31.3.226 · Cited by 107
Selective neuropathy and preserved vascular responses in the diabetic Charcot foot
Stevens, M., EDMONDS, M. E., Foster, A. V., & Watkins, P. (1992) · Diabetologia · doi:10.1007/bf00402547 · Cited by 95
Fisher, B. M., Gillen, G., Lindop, G. B. M., Dargie, H. J., & Frier, B. M. (1986) · Diabetologia · doi:10.1007/bf00870280 · Cited by 76
Problems of repeated significance testing
Abt, K. (1981) · Controlled Clinical Trials · doi:10.1016/0197-2456(81)90042-8 · Cited by 61
Klein, R. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430070101012 · Cited by 42
Gerson, M. C., Khoury, J. C., Hertzberg, V., Fischer, E. E., & Scott, R. C. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90343-2 · Cited by 32
Lachin, J. M., & Wei, L. J. (1988) · Biometrics · doi:10.2307/2531864 · Cited by 25
Cited by
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Metadata
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1999-01-01
- Volume
- 22
- Issue
- 1
- Pages
- 99-111
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2734011609
- Cited by
- 660
- References
- 44
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.